Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2026-01-28 @ 5:00 PM
Study NCT ID:
NCT04338620
Status:
UNKNOWN
Last Update Posted:
2023-03-06
First Post:
2020-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC
Sponsor:
Tang-Du Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-06
First Submit QC Date:
None
Study First Post Date:
2020-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-01
Last Update Post Date:
2023-03-06
Last Update Post Date Type:
ACTUAL